Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study

References

• American Cancer Society . Cancer facts & figures 2017. Cancer Facts Fig 2017. 2017.
   Google Scholar
• Siegel RL , Miller KD , Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.
   PubMed Web of Science ®Google Scholar
• Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013;19(34):5598–5606.
   PubMed Web of Science ®Google Scholar
• Laccetti AL , Pruitt SL , Xuan L , et al. Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual. J Natl Cancer Inst. 2015;107(4):djv002–djv002.
   PubMedGoogle Scholar
• Tournoux C , Katsahian S , Chevret S , et al. Factors influencing inclusion of patients with malignancies in clinical trials: a review. Cancer. 2006;106:258–270.
   PubMed Web of Science ®Google Scholar
• Van Spall HGC , Toren A , Kiss A , et al. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. Jama. 2007;297(11):1233–1240.
   PubMed Web of Science ®Google Scholar
• Surveillance Research Program, National Cancer Institute SEER*Stat software . version 8.3.4. 20 September 2017. Available from: www.seer.cancer.gov/seerstat
   Google Scholar
• National Cancer Institute SSB . 2007. Cancer Incidence – surveillance, epidemiology, and end results (SEER) registries research data. surveillance, epidemiology, and end results (SEER) program. 20 September 2017. Available from: http://www.seer.cancer.gov.
   Google Scholar
• Rothwell PM. External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet. 2005;365:82–93.
   PubMed Web of Science ®Google Scholar
• Lara PN , Higdon R , Lim N , et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001;19(6):1728–1733.
   PubMed Web of Science ®Google Scholar
• Gerber DE , Laccetti AL , Xuan L , et al. Impact of prior cancer on eligibility for lung cancer clinical trials. J Natl Cancer Inst. 2014;106(11). pii: dju302. doi:10.1093/jnci/dju302.
   PubMedGoogle Scholar
• Kotwall CA , Mahoney LJ , Myers RE , et al. Reasons for non-entry in randomized clinical-trials for breast-cancer - a single institutional study. J Surg Oncol. 1992;50(2):125–129.
   PubMed Web of Science ®Google Scholar
• Smyth EC , Tarazona N , Peckitt C , et al. Exclusion of gastrointestinal cancer patients with prior cancer from clinical trials: is this justified? Clin Colorectal Cancer. 2016;15(2):e53–9.
   PubMed Web of Science ®Google Scholar
• Pruitt SL , Laccetti AL , Xuan L , et al. Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer. Br J Cancer [Internet]. 2017 Mar 14 cited 2017 Jun 3 ;116(6):717–725. Available from: http://www.nature.com/doifinder/10.1038/bjc.2017.27
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman O , Cheung WY . Subsequent thoracic cancers among patients diagnosed with lung cancer: a SEER database analysis. Curr Med Res Opin. 2017;33(11):1–9.
   Web of Science ®Google Scholar
• Yang CS , Chen X , Etiology TS . Prevention of esophageal cancer. Gastrointest Tumors [Internet]. 2016;3(1):3–16.
   PubMed Web of Science ®Google Scholar
• Shapiro JA , Jacobs EJ , Thun MJ . Cigar smoking in men and risk of death from tobacco-related cancers. J Natl Cancer Inst. 2000;92(4):333–337.
   PubMedGoogle Scholar
• Gandini S , Botteri E , Iodice S , et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer. 2008;122(1):155–164.
   PubMed Web of Science ®Google Scholar
• Boffetta P , Garfinkel L . Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology. 1990;1(5):342–348.
   PubMedGoogle Scholar
• Chao C . Associations between beer, wine, and liquor consumption and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2436–2447.
   PubMed Web of Science ®Google Scholar
• Arnal MJD , Arenas ÁF , Arbeloa ÁL . Esophageal cancer: risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol. 2015;21:7933–7943.
   PubMed Web of Science ®Google Scholar